Hong Kong Pharma Closes Public Offering

Dow Jones

Jan 17, 2025

By Katherine Hamilton

Hong Kong Pharma Digital Technology Holdings closed its initial public offering of 1.4 million shares.

The over-the-counter pharmaceutical services company priced the IPO at $4 a share.

Shares began trading on Nasdaq on Jan. 15 under the symbol HKPD, the company said.

The aggregate gross proceeds from the offering were about $5.6 million before deducting underwriting discounts. Hong Kong Pharma plans to use proceeds to develop its supply chain enterprise resource planning systems, procure warehouse equipment to improve efficiency, expand its sales and marketing team, and fund general working capital.

The company has also granted underwriters a 45-day option to purchase up to 150,000 shares to cover over-allotments at the IPO price.

Write to Katherine Hamilton at katherine.hamilton@wsj.com

(END) Dow Jones Newswires

January 16, 2025 14:40 ET (19:40 GMT)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2504944362"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2504944362\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2504944362?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-01-17 03:40","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2504944362","market":"sg","top_or_hot":-1,"title":"Hong Kong Pharma Closes Public Offering","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  By Katherine Hamilton \n</p>\n<pre>\n \n</pre>\n<p>\n  Hong Kong Pharma Digital Technology Holdings closed its initial public offering of 1.4 million shares. \n</p>\n<p>\n  The over-the-counter pharmaceutical services company priced the IPO at $4 a share. \n</p>\n<p>\n  Shares began trading on Nasdaq on Jan. 15 under the symbol HKPD, the company said. \n</p>\n<p>\n  The aggregate gross proceeds from the offering were about $5.6 million before deducting underwriting discounts. Hong Kong Pharma plans to use proceeds to develop its supply chain enterprise resource planning systems, procure warehouse equipment to improve efficiency, expand its sales and marketing team, and fund general working capital. \n</p>\n<p>\n  The company has also granted underwriters a 45-day option to purchase up to 150,000 shares to cover over-allotments at the IPO price. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Katherine Hamilton at katherine.hamilton@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  January 16, 2025 14:40 ET (19:40 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Hong Kong Pharma Closes Public Offering</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHong Kong Pharma Closes Public Offering\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2025-01-17 03:40</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  By Katherine Hamilton \n</p>\n<pre>\n \n</pre>\n<p>\n  Hong Kong Pharma Digital Technology Holdings closed its initial public offering of 1.4 million shares. \n</p>\n<p>\n  The over-the-counter pharmaceutical services company priced the IPO at $4 a share. \n</p>\n<p>\n  Shares began trading on Nasdaq on Jan. 15 under the symbol HKPD, the company said. \n</p>\n<p>\n  The aggregate gross proceeds from the offering were about $5.6 million before deducting underwriting discounts. Hong Kong Pharma plans to use proceeds to develop its supply chain enterprise resource planning systems, procure warehouse equipment to improve efficiency, expand its sales and marketing team, and fund general working capital. \n</p>\n<p>\n  The company has also granted underwriters a 45-day option to purchase up to 150,000 shares to cover over-allotments at the IPO price. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Katherine Hamilton at katherine.hamilton@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  January 16, 2025 14:40 ET (19:40 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"HKPD","symbol_name":"生研生物","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2504944362","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2504944362","pubTimestamp":1737056400,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Hong Kong Pharma Digital Technology Holdings closed its initial public offering of 1.4 million shares.The over-the-counter pharmaceutical services company priced the IPO at $4 a share.Shares began trading on Nasdaq on Jan. 15 under the symbol HKPD, the company said.The aggregate gross proceeds from the offering were about $5.6 million before deducting underwriting discounts. Hong Kong Pharma plans to use proceeds to develop its supply chain enterprise resource planning systems, procure warehouse equipment to improve efficiency, expand its sales and marketing team, and fund general working capital.The company has also granted underwriters a 45-day option to purchase up to 150,000 shares to cover over-allotments at the IPO price.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"HKPD":"生研生物"},"translate_title":"香港医药结束公开发售","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"HKPD":0.9},"content_text":"By Katherine Hamilton \n\n\n \n\n\n  Hong Kong Pharma Digital Technology Holdings closed its initial public offering of 1.4 million shares. \n\n\n  The over-the-counter pharmaceutical services company priced the IPO at $4 a share. \n\n\n  Shares began trading on Nasdaq on Jan. 15 under the symbol HKPD, the company said. \n\n\n  The aggregate gross proceeds from the offering were about $5.6 million before deducting underwriting discounts. Hong Kong Pharma plans to use proceeds to develop its supply chain enterprise resource planning systems, procure warehouse equipment to improve efficiency, expand its sales and marketing team, and fund general working capital. \n\n\n  The company has also granted underwriters a 45-day option to purchase up to 150,000 shares to cover over-allotments at the IPO price. \n\n\n \n\n\n  Write to Katherine Hamilton at katherine.hamilton@wsj.com \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  January 16, 2025 14:40 ET (19:40 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}